An evaluation of the present treatment of toxic goiter. 1948

G B KENT

UI MeSH Term Description Entries
D006042 Goiter Enlargement of the THYROID GLAND that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (HYPOTHYROIDISM), or hormone overproduction (HYPERTHYROIDISM). Goiter may be congenital or acquired, sporadic or endemic (GOITER, ENDEMIC). Goiters
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013971 Thyrotoxicosis A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING. Thyrotoxicoses

Related Publications

G B KENT
January 1949, American practitioner and digest of treatment,
G B KENT
October 1947, Mississippi Valley medical journal (Quincy, Ill),
G B KENT
January 1952, The Journal of clinical endocrinology and metabolism,
G B KENT
September 1954, Minnesota medicine,
G B KENT
January 1951, Journal of the National Medical Association,
G B KENT
June 1973, Khirurgiia,
G B KENT
May 1951, Postgraduate medicine,
G B KENT
February 1987, Nederlands tijdschrift voor geneeskunde,
G B KENT
July 1969, Postgraduate medicine,
Copied contents to your clipboard!